[4] A fourth route, intranasal delivery, has been explored in the context of neurological applications on the premise that the nasal mucosa provides a direct pathway to the central nervous system via the olfactory nerve
On July 2324, the Pharmacy Compounding Advisory Committee meets to reconsider BPC-157, TB-500, KPV and MOTS-C for the 503A list peptides that have sat in a regulatory gray zone since 2023
The COA documentation satisfies our institutional procurement requirements
Francis SMS, Larsen JE, Pavey SJ, Bowman RV, Hayward NK, Fong KM, Yang I: Expression profiling identifies genes involved in emphysema severity
It's worth noting that the available scientific literature on TB-500 is limited, and most of the reported side effects are based on observation by researchers [11]
Some peptides have more robust research backing their benefits than others